Topical summits in Dubai, Berlin, Nanjing, Basel, Lisbon, London and other cities discussed the uniqueness of Dr Allen's ...

Therapeutic Dr Allen's Devices are designed to treat different chronic health conditions, including kidney stones (known as nephrolithiasis), prostate enlargement (commonly known as BPH), chronic ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised prostate cancer.

Shock wave therapy improves pain and urinary symptoms in men with type IIIB chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

Dillard's — Shares fell 7% after the department store posted weaker-than-expected revenue in the holiday quarter.

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

Global Urology Devices Market OverviewThe global urology devices market is poised for steady expansion and is projected to grow at a CAGR of approximately 6–7% during the forecast period from 2024 to ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...